[ Price : $8.95]
After waiting 10 weeks, FDA opens a search for a new CDER director able to help define drug regulatory policy for the next generat...[ Price : $8.95]
Against a rising sense of crisis in FDAs ability to continue its mission, the agencys Science Board Advisory Committee unanimously...[ Price : $8.95]
Rep. Henry Waxman asks FDA commissioner Andrew von Eschenbach not to proceed with a draft guidance allowing companies to distribut...[ Price : $8.95]
Five science and consumer activists groups ask FDA commissioner Andrew von Eschenbach to reconsider an advisory committee conflict...[ Price : $8.95]
FDA grants fast track to AVI BioPharma for AVI-4658, an investigational therapy for treating Duchenne muscular dystrophy.[ Price : $8.95]
FDA proposes several revisions to its GMP regulations to modernize requirements for drug and biologic manufacturers.[ Price : $8.95]
FDAs Oncology Drugs Advisory Committee is asked to consider what efficacy measure is appropriate for Genentechs Avastin to be appr...[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information on CGMP regulations for Type A medicated articles to the...